2,605
Views
31
CrossRef citations to date
0
Altmetric
Research Paper

Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies

, , , , , , , , , , & show all
Pages 231-247 | Received 20 Jun 2017, Accepted 08 Oct 2017, Published online: 26 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Haijie Hu, Min Liu & Shuang Sun. (2021) Pore-Forming Toxins During Bacterial Infection: Molecular Mechanisms and Potential Therapeutic Targets. Drug Design, Development and Therapy 15, pages 3773-3781.
Read now
Jordi Rello, Francesca Romana Parisella & Antonio Perez. (2019) Alternatives to antibiotics in an era of difficult-to-treat resistance: new insights. Expert Review of Clinical Pharmacology 12:7, pages 635-642.
Read now

Articles from other publishers (29)

Laxmi Kumari Gupta, Johiruddin Molla & Ashish A. Prabhu. (2023) Story of Pore-Forming Proteins from Deadly Disease-Causing Agents to Modern Applications with Evolutionary Significance. Molecular Biotechnology.
Crossref
Ahlam N. QerqezRui P. Silva & Jennifer A. Maynard. (2023) Outsmarting Pathogens with Antibody Engineering. Annual Review of Chemical and Biomolecular Engineering 14:1, pages 217-241.
Crossref
Peter T. Buckley, Rita Chan, Jeffrey Fernandez, Jinquan Luo, Keenan A. Lacey, Ashley L. DuMont, Aidan O’Malley, Randall J. Brezski, Songmao Zheng, Thomas Malia, Brian Whitaker, Adam Zwolak, Angela Payne, Desmond Clark, Martin Sigg, Eilyn R. Lacy, Anna Kornilova, Debra Kwok, Steve McCarthy, Bingyuan Wu, Brian Morrow, Jennifer Nemeth-Seay, Ted Petley, Sam Wu, William R. Strohl, Anthony Simon Lynch & Victor J. Torres. (2023) Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections. Cell Host & Microbe 31:5, pages 751-765.e11.
Crossref
Kusum Kharga, Lokender Kumar & Sanjay Kumar Singh Patel. (2023) Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis. Biomedicines 11:3, pages 765.
Crossref
Andreas F. Haag, Lassi Liljeroos, Paolo Donato, Clarissa Pozzi, Tarcisio Brignoli, Matthew J. Bottomley, Fabio Bagnoli & Isabel Delany. (2023) In Vivo Gene Expression Profiling of Staphylococcus aureus during Infection Informs Design of Stemless Leukocidins LukE and -D as Detoxified Vaccine Candidates . Microbiology Spectrum 11:1.
Crossref
Moona Sakari, Arttu Laisi & Arto T. Pulliainen. (2022) Exotoxin-Targeted Drug Modalities as Antibiotic Alternatives. ACS Infectious Diseases 8:3, pages 433-456.
Crossref
Caroline Boulouis, Edwin Leeansyah, Srikanth Mairpady Shambat, Anna Norrby-Teglund & Johan K. Sandberg. (2022) Mucosa-Associated Invariant T Cell Hypersensitivity to Staphylococcus aureus Leukocidin ED and Its Modulation by Activation . The Journal of Immunology 208:5, pages 1170-1179.
Crossref
Parsa Pishva, Irmak C. Kayalan, Fatma Sert & Meral Yüce. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 627 660 .
Lucía Fernández, María Dolores Cima-Cabal, Ana Catarina Duarte, Ana Rodríguez, María del Mar García-Suárez & Pilar García. (2021) Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy. Antibiotics 10:8, pages 1000.
Crossref
Jonah Clegg, Elisabetta Soldaini, Rachel M. McLoughlin, Stephen Rittenhouse, Fabio Bagnoli & Sanjay Phogat. (2021) Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies. Frontiers in Immunology 12.
Crossref
Rajan P. Adhikari. (2021) Staphylococcal Infections: Host and Pathogenic Factors. Microorganisms 9:5, pages 1080.
Crossref
Viktoria RungelrathFrank R. DeLeo. (2021) Staphylococcus aureus , Antibiotic Resistance, and the Interaction with Human Neutrophils . Antioxidants & Redox Signaling 34:6, pages 452-470.
Crossref
Jelle Vlaeminck, Dina Raafat, Kristin Surmann, Leen Timbermont, Nicole Normann, Bret Sellman, Willem J. B. van Wamel & Surbhi Malhotra-Kumar. (2020) Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia. Toxins 12:11, pages 721.
Crossref
Philipp Starkl, Martin L. Watzenboeck, Lauren M. Popov, Sophie Zahalka, Anastasiya Hladik, Karin Lakovits, Mariem Radhouani, Arvand Haschemi, Thomas Marichal, Laurent L. Reber, Nicolas Gaudenzio, Riccardo Sibilano, Lukas Stulik, Frédéric Fontaine, André C. Mueller, Manuel R. Amieva, Stephen J. Galli & Sylvia Knapp. (2020) IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against Staphylococcus aureus. Immunity 53:4, pages 793-804.e9.
Crossref
Monique R. Bennett & Isaac P. Thomsen. (2020) Epidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease. Toxins 12:6, pages 408.
Crossref
Norman C. Peterson, Prathap Kumar Mahalingaiah, Aaron Fullerton & Matteo Di Piazza. (2020) Application of microphysiological systems in biopharmaceutical research and development. Lab on a Chip 20:4, pages 697-708.
Crossref
Despoina Koulenti, Elena Xu, Andrew Song, Isaac Yin Sum Mok, Drosos E. Karageorgopoulos, Apostolos Armaganidis, Sotirios Tsiodras & Jeffrey Lipman. (2020) Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms 8:2, pages 191.
Crossref
Nikolina TrstenjakDalibor Milić, Melissa A. GraewertHarald RouhaDmitri SvergunKristina Djinović-Carugo, Eszter Nagy & Adriana Badarau. (2019) Molecular mechanism of leukocidin GH–integrin CD11b/CD18 recognition and species specificity. Proceedings of the National Academy of Sciences 117:1, pages 317-327.
Crossref
Helene Marbach, Katharina Mayer, Claus Vogl, Jean Y. H. Lee, Ian R. Monk, Daniel O. Sordelli, Fernanda R. Buzzola, Monika Ehling-Schulz & Tom Grunert. (2019) Within-host evolution of bovine Staphylococcus aureus selects for a SigB-deficient pathotype characterized by reduced virulence but enhanced proteolytic activity and biofilm formation. Scientific Reports 9:1.
Crossref
Zoltan Magyarics, Fraser Leslie, Johann Bartko, Harald Rouha, Steven Luperchio, Christian Schörgenhofer, Michael Schwameis, Ulla Derhaschnig, Heimo Lagler, Leopold Stiebellehner, Christa Firbas, Susanne Weber, Ed Campanaro, Bernd Jilma, Eszter Nagy & Chris Stevens. (2019) Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers . Antimicrobial Agents and Chemotherapy 63:8.
Crossref
Jennifer A. Grousd, Helen E. Rich & John F. Alcorn. (2019) Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia. Clinical Microbiology Reviews 32:3.
Crossref
Michael P. Motley, Kasturi Banerjee & Bettina C. Fries. (2019) Monoclonal antibody-based therapies for bacterial infections. Current Opinion in Infectious Diseases 32:3, pages 210-216.
Crossref
Lukas Stulik, Harald Rouha, Delphine Labrousse, Zehra Claire Visram, Adriana Badarau, Barbara Maierhofer, Karin Groß, Susanne Weber, Miroslava Dominis Kramarić, Ines Glojnarić, Gábor Nagy, Delphine Croisier & Eszter Nagy. (2019) Preventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid. Scientific Reports 9:1.
Crossref
Nikolina Trstenjak, Lukas Stulik, Harald Rouha, Jakub Zmajkovic, Manuel Zerbs, Eszter Nagy & Adriana Badarau. (2019) Adaptation of the Staphylococcus aureus leukocidin LukGH for the rabbit host by protein engineering . Biochemical Journal 476:2, pages 275-292.
Crossref
Tamara Escajadillo & Victor Nizet. (2018) Pharmacological Targeting of Pore-Forming Toxins as Adjunctive Therapy for Invasive Bacterial Infection. Toxins 10:12, pages 542.
Crossref
Eveline M. Boerhout, Ad P. Koets, Tanja G. T. Mols-Vorstermans, Piet J. M. Nuijten, Mathieu J. H. Hoeijmakers, Victor P. M. G. Rutten & Jetta J. E. Bijlsma. (2018) The antibody response in the bovine mammary gland is influenced by the adjuvant and the site of subcutaneous vaccination. Veterinary Research 49:1.
Crossref
Chendi Jing, Chenghua Liu, Fangjie Liu, Yaping Gao, Yu Liu, Zhangchun Guan, Bo Xuan, Yanyan Yu & Guang Yang. (2018) Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus. BMC Microbiology 18:1.
Crossref
Assaf Raz, Anna Serrano, Maneesha Thaker, Tricia Alston & Vincent A. Fischetti. (2018) Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model. Antimicrobial Agents and Chemotherapy 62:10.
Crossref
Samareh Azeredo da Silveira & Antonio Perez. (2018) CAL02 Liposomes and Other Antitoxins: A New Generation of Anti-Infectives. Clinical Pulmonary Medicine 25:3, pages 84-88.
Crossref